Ionis Pharmaceuticals (IONS) Current Taxes (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Current Taxes of $2.9 million for Q2 2026, up 3451.85% year-over-year from $81000.0 in Q2 2025, and little changed quarter-over-quarter from $2.9 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Current Taxes (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Current Taxes history runs 11 years deep, the most recent figure standing at $2.9 million for Q2 2026.
- In Q2 2026, Current Taxes rose 3451.85% year-over-year to $2.9 million; the TTM figure through Jun 2026 stood at $2.9 million (up 3451.85% YoY), while the FY2025 annual figure was $2.7 million, up 7879.41% from the prior year.
- Current Taxes for Q2 2026 stood at $2.9 million, roughly flat from $2.9 million in the prior quarter.
- The five-year high for Current Taxes was $31.1 million in Q3 2023, with the low at $14000.0 in Q2 2022.
- The 5-year median for Current Taxes is $1.5 million (2022), against an average of $5.2 million.
- The sharpest annual moves came in 2023 and 2024: Current Taxes soared 194087.5% in 2023, then tumbled 99.87% in 2024.
- Ionis Pharmaceuticals' Current Taxes stood at $6.2 million in 2022, then slumped by 65.58% to $2.2 million in 2023, then slumped by 98.42% to $34000.0 in 2024, then jumped by 7879.41% to $2.7 million in 2025, then gained by 6.04% to $2.9 million in 2026.
- Business Quant data shows IONS's Current Taxes at $2.9 million in Q2 2026, $2.9 million in Q1 2026, and $2.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Mn |
| Mar 31, 2026 | 2.87 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 284,000.00 |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 31.07 Mn |
| Jun 30, 2023 | 24.73 Mn |
| Mar 31, 2023 | 17.29 Mn |
| Dec 31, 2022 | 6.25 Mn |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 901,000.00 |
| Dec 31, 2021 | 36,000.00 |
| Sep 30, 2021 | 450,000.00 |